|
Status |
Public on Aug 15, 2009 |
Title |
patient40;female;breast tumor;Letrozole, 2.5mg/day,oral, 3 months |
Sample type |
RNA |
|
|
Source name |
human breast tumor
|
Organism |
Homo sapiens |
Characteristics |
gender: female tissue: breast tumor treatment: Letrozole, 2.5mg/day,oral, 3 months
|
Extracted molecule |
total RNA |
Extraction protocol |
Trizol extraction of total RNA was performed according to the manufacturer's instructions.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Expression Analysis Technical Manual, 2001, Affymetrix).
|
|
|
Hybridization protocol |
Following fragmentation, 5 ug of cRNA were hybridized on U133 GeneChip following the recommended procedures. GeneChips were washed and stained according to Affymetrix protocol EukGE-2v4.
|
Scan protocol |
GeneChips were scanned using an Affymetrix GeneChip Scanner (Agilent).
|
Description |
breast tumor biopsy
|
Data processing |
dChip version2006
|
|
|
Submission date |
Jan 25, 2008 |
Last update date |
Jul 30, 2014 |
Contact name |
Chad Creighton |
E-mail(s) |
[email protected]
|
Organization name |
Baylor College of Medicine
|
Department |
Biostatistics, Ducan Cancer Center
|
Street address |
One Baylor Plaza, Mail Stop: BCM305
|
City |
Houston |
State/province |
TX |
ZIP/Postal code |
77030 |
Country |
USA |
|
|
Platform ID |
GPL570 |
Series (1) |
GSE10281 |
Letrozole (Femara) early response to treatment |
|